Filing Details

Accession Number:
0000950103-14-001271
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-21 19:55:14
Reporting Period:
2014-02-19
Filing Date:
2014-02-21
Accepted Time:
2014-02-21 19:55:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1275014 Ultra Clean Holdings Inc UCTT Semiconductors & Related Devices (3674) 611430858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1283710 L Clarence Granger Ultra Clean Holdings, Inc.
26462 Corporate Ave
Hayward CA 94545
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-19 20,834 $1.11 374,410 No 4 M Direct
Common Stock Acquisiton 2014-02-19 29,166 $6.55 403,576 No 4 M Direct
Common Stock Disposition 2014-02-19 100,000 $13.07 303,576 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-19 20,834 $0.00 20,834 $1.11
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-19 29,166 $0.00 29,166 $6.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-02-27 2019-02-27 No 4 M Direct
334,157 2006-05-09 2015-05-09 No 4 M Direct
Footnotes
  1. Sale of shares pursuant to Rule 10b5-1 Plan adopted December 7, 2012
  2. This is the weighted average sale price. Shares were sold in multiple transactions at prices from $13.03 to $13.10. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
  3. The option becomes exercisable over 4 years from the date of grant, with 25% becoming exercisable after the first year and monthly thereafter.